Autologous Cell Therapy Market - Global Outlook and Forecast 2023-2028

Report ID: 1371212 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Autologous Cell Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Autologous Cell Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Autologous Cell Therapy Overall Market Size
    2.1 Global Autologous Cell Therapy Market Size: 2021 VS 2028
    2.2 Global Autologous Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Autologous Cell Therapy Players in Global Market
    3.2 Top Global Autologous Cell Therapy Companies Ranked by Revenue
    3.3 Global Autologous Cell Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Autologous Cell Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Autologous Cell Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Autologous Cell Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Autologous Cell Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Autologous Cell Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Autologous Cell Therapy Market Size Markets, 2021 & 2028
        4.1.2 Bone Marrow
        4.1.3 Epidermis
    4.2 By Type - Global Autologous Cell Therapy Revenue & Forecasts
        4.2.1 By Type - Global Autologous Cell Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Autologous Cell Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Autologous Cell Therapy Market Size, 2021 & 2028
        5.1.2 Neurology
        5.1.3 Orthopedics
        5.1.4 Cancer
        5.1.5 Wound Healing
        5.1.6 Other
    5.2 By Application - Global Autologous Cell Therapy Revenue & Forecasts
        5.2.1 By Application - Global Autologous Cell Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Autologous Cell Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Autologous Cell Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Autologous Cell Therapy Revenue & Forecasts
        6.2.1 By Region - Global Autologous Cell Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Autologous Cell Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Autologous Cell Therapy Revenue, 2017-2028
        6.3.2 US Autologous Cell Therapy Market Size, 2017-2028
        6.3.3 Canada Autologous Cell Therapy Market Size, 2017-2028
        6.3.4 Mexico Autologous Cell Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Autologous Cell Therapy Revenue, 2017-2028
        6.4.2 Germany Autologous Cell Therapy Market Size, 2017-2028
        6.4.3 France Autologous Cell Therapy Market Size, 2017-2028
        6.4.4 U.K. Autologous Cell Therapy Market Size, 2017-2028
        6.4.5 Italy Autologous Cell Therapy Market Size, 2017-2028
        6.4.6 Russia Autologous Cell Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Autologous Cell Therapy Market Size, 2017-2028
        6.4.8 Benelux Autologous Cell Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Autologous Cell Therapy Revenue, 2017-2028
        6.5.2 China Autologous Cell Therapy Market Size, 2017-2028
        6.5.3 Japan Autologous Cell Therapy Market Size, 2017-2028
        6.5.4 South Korea Autologous Cell Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Autologous Cell Therapy Market Size, 2017-2028
        6.5.6 India Autologous Cell Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Autologous Cell Therapy Revenue, 2017-2028
        6.6.2 Brazil Autologous Cell Therapy Market Size, 2017-2028
        6.6.3 Argentina Autologous Cell Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Autologous Cell Therapy Revenue, 2017-2028
        6.7.2 Turkey Autologous Cell Therapy Market Size, 2017-2028
        6.7.3 Israel Autologous Cell Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Autologous Cell Therapy Market Size, 2017-2028
        6.7.5 UAE Autologous Cell Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 BioTime
        7.1.1 BioTime Corporate Summary
        7.1.2 BioTime Business Overview
        7.1.3 BioTime Autologous Cell Therapy Major Product Offerings
        7.1.4 BioTime Autologous Cell Therapy Revenue in Global Market (2017-2022)
        7.1.5 BioTime Key News
    7.2 Pharmicell
        7.2.1 Pharmicell Corporate Summary
        7.2.2 Pharmicell Business Overview
        7.2.3 Pharmicell Autologous Cell Therapy Major Product Offerings
        7.2.4 Pharmicell Autologous Cell Therapy Revenue in Global Market (2017-2022)
        7.2.5 Pharmicell Key News
    7.3 BrainStorm Cell Therapeutics
        7.3.1 BrainStorm Cell Therapeutics Corporate Summary
        7.3.2 BrainStorm Cell Therapeutics Business Overview
        7.3.3 BrainStorm Cell Therapeutics Autologous Cell Therapy Major Product Offerings
        7.3.4 BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue in Global Market (2017-2022)
        7.3.5 BrainStorm Cell Therapeutics Key News
    7.4 Opexa Therapeutics
        7.4.1 Opexa Therapeutics Corporate Summary
        7.4.2 Opexa Therapeutics Business Overview
        7.4.3 Opexa Therapeutics Autologous Cell Therapy Major Product Offerings
        7.4.4 Opexa Therapeutics Autologous Cell Therapy Revenue in Global Market (2017-2022)
        7.4.5 Opexa Therapeutics Key News
    7.5 Vericel Corporation
        7.5.1 Vericel Corporation Corporate Summary
        7.5.2 Vericel Corporation Business Overview
        7.5.3 Vericel Corporation Autologous Cell Therapy Major Product Offerings
        7.5.4 Vericel Corporation Autologous Cell Therapy Revenue in Global Market (2017-2022)
        7.5.5 Vericel Corporation Key News
    7.6 Regeneus
        7.6.1 Regeneus Corporate Summary
        7.6.2 Regeneus Business Overview
        7.6.3 Regeneus Autologous Cell Therapy Major Product Offerings
        7.6.4 Regeneus Autologous Cell Therapy Revenue in Global Market (2017-2022)
        7.6.5 Regeneus Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Autologous Cell Therapy Market Opportunities & Trends in Global Market
    Table 2. Autologous Cell Therapy Market Drivers in Global Market
    Table 3. Autologous Cell Therapy Market Restraints in Global Market
    Table 4. Key Players of Autologous Cell Therapy in Global Market
    Table 5. Top Autologous Cell Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Autologous Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Autologous Cell Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Autologous Cell Therapy Product Type
    Table 9. List of Global Tier 1 Autologous Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Autologous Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Autologous Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Autologous Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Autologous Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Autologous Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Autologous Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Autologous Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Autologous Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Autologous Cell Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Autologous Cell Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Autologous Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Autologous Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. BioTime Corporate Summary
    Table 31. BioTime Autologous Cell Therapy Product Offerings
    Table 32. BioTime Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Pharmicell Corporate Summary
    Table 34. Pharmicell Autologous Cell Therapy Product Offerings
    Table 35. Pharmicell Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. BrainStorm Cell Therapeutics Corporate Summary
    Table 37. BrainStorm Cell Therapeutics Autologous Cell Therapy Product Offerings
    Table 38. BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Opexa Therapeutics Corporate Summary
    Table 40. Opexa Therapeutics Autologous Cell Therapy Product Offerings
    Table 41. Opexa Therapeutics Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Vericel Corporation Corporate Summary
    Table 43. Vericel Corporation Autologous Cell Therapy Product Offerings
    Table 44. Vericel Corporation Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Regeneus Corporate Summary
    Table 46. Regeneus Autologous Cell Therapy Product Offerings
    Table 47. Regeneus Autologous Cell Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Autologous Cell Therapy Segment by Type in 2021
    Figure 2. Autologous Cell Therapy Segment by Application in 2021
    Figure 3. Global Autologous Cell Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Autologous Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Autologous Cell Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Autologous Cell Therapy Revenue in 2021
    Figure 8. By Type - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 12. US Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 24. China Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Autologous Cell Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Autologous Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. BioTime Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Pharmicell Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. BrainStorm Cell Therapeutics Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Opexa Therapeutics Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Vericel Corporation Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Regeneus Autologous Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
60
Frequently Asked Questions
Autologous Cell Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Autologous Cell Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Autologous Cell Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports